Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Addressing Metabolic Dysfunction as an Independent Cancer Risk Factor Accumulating evidence positions metabolic dysfunction characterised by insulin resistance, hepatic steatosis, dyslipidaemia, and visceral adiposity as a more powerful and proximate predictor of cancer risk than elevated body weight alone
No clinically significant changes in the different parameters of glucose metabolism from baseline to end of treatment were observed
HSA/FSA Eligible | Weight loss | Testosterone | Growth Hormone| NAD+| BoTox & more
Consult a healthcare practitioner prior to use if you are pregnant or breastfeeding
US$ 29.80
US$ 29.31
US$ 29.12
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
US$ 21.68
:max_bytes(150000):strip_icc():focal(749x0:751x2)/gpl-1-jabs-052226-1-010a064224da4f85bf4c6ea0952739c8.jpg)
US$ 29.02
